Connect Biopharma Holdings Ltd (CNTB) is a Healthcare · Biotechnology company listed on NASDAQ. Price $1.31 (+1.55%), Market cap $0.13B, 52-week low–high $0.75 ~ $3.69.
Connect Biopharma Holdings Limited operates as a clinical-stage biopharmaceutical company in the United States. It develops rademikibart, a human monoclonal IgG4 antibody directed against IL-4Ra in two Phase 2 trials for the treatment of acute exacerbations of asthma and chronic obstructive pulmonary disease (COPD). The company was founded in 2012 and is headquartered in San Diego, California.
Financial statements, price targets, institutional (13F) holdings and related news for Connect Biopharma Holdings Ltd are updated in real time on BlackAll Trade.
Connect Biopharma Holdings Ltd trades at $1.31 (+1.55%). Real-time quotes and charts are available on BlackAll Trade.
Connect Biopharma Holdings Ltd has a market cap of about $0.13B.
Connect Biopharma Holdings Limited operates as a clinical-stage biopharmaceutical company in the United States. It develops rademikibart, a human monoclonal IgG4 antibody directed against IL-4Ra in tw